MRI identifies disrupted cerebral development in medulloblastoma patients

Asim K Bag1, Joseph Holtrop1, John O Glass1

  • 1Radiology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.

Brain Communications
|March 6, 2025
PubMed

Insights

Brain microstructural changes and cortical thinning occur in medulloblastoma patients before adjuvant therapy. These alterations, linked to tumor development or surgery, impact cognitive functions in survivors.

Area of Science:

  • Neuroscience
  • Pediatric Oncology
  • Radiology

Background:

  • Cognitive decline in medulloblastoma survivors is often linked to adjuvant therapies.
  • Pre-treatment factors like tumor development and surgery's impact on brain microstructure are less understood.

Purpose of the Study:

  • To assess pre-adjuvant therapy cortical thickness and cerebral microstructural integrity in medulloblastoma patients.
  • To investigate the role of pre-treatment factors in brain alterations.

Main Methods:

  • Cross-sectional imaging of medulloblastoma patients (n=30) post-surgery and pre-adjuvant therapy.
  • Comparison with age-matched healthy controls (n=35).
  • Analysis of microstructural integrity (fractional anisotropy, diffusivities) and cortical thickness, surface area, and volume.

Main Results:

  • Medulloblastoma patients exhibited increased diffusivity and decreased fractional anisotropy in most cerebral white and grey matter.
  • Reduced cortical thickness was observed in frontal, parietal, temporal, and paracentral regions.
  • Significant cerebral microstructural alterations were present before radiation or chemotherapy.

Conclusions:

  • Cerebellar insult from tumor or resection surgery contributes to compromised cerebral grey and white matter integrity before adjuvant therapy.
  • Cortical thinning in specific regions suggests impaired development affecting executive function, language, and attention in medulloblastoma survivors.